ArticleEuropean journal of nuclear medicine and molecular imaging2025

Expanding the scope of PSMA-RLT: evaluating treatment in challenging mCRPC patients with poor performance status (ECOG 3).

Moritz B Bastian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.